Telemetry Investments, L.L.C. Veru Inc. Transaction History

Telemetry Investments, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.55 - $6.41 $68,250 - $96,150	-15,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.89 - $9.73 $88,350 - $145,950	15,000 New	15,000 $88,000
Q1 2021 May 17, 2021	SELL	$8.05 - $20.78 $281,943 - $727,798	-35,024 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.36 - $9.99 $11,637 - $49,260	4,931 Added 16.39%	35,024 $303,000
Q3 2020 Nov 16, 2020	BUY	$2.58 - $3.36 $77,639 - $101,112	30,093 New	30,093 $79,000

115

58M

539K

367K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $62.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Telemetry Investments, L.L.C. with notifications on news.